Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$65.8M |
| 2 |
iShares MSCI Japan ETF
EWJ
|
+$65.6M |
| 3 |
Lowe's Companies
LOW
|
+$61.6M |
| 4 |
iShares MSCI Brazil ETF
EWZ
|
+$59.2M |
| 5 |
iShares MSCI India ETF
INDA
|
+$40.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$274M |
| 2 |
iShares MSCI Taiwan ETF
EWT
|
+$93.6M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$50.9M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$48.2M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$37.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 14.45% |
| 2 | Technology | 13.1% |
| 3 | Consumer Discretionary | 12.53% |
| 4 | Healthcare | 11.49% |
| 5 | Industrials | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1551
DRDGold
DRD
$2.05B
| $61K | ﹤0.01% |
15,761
-2,223
| -12% | -$7.5K |
2017 Q2
1 quarter
|
|
1552
Aptevo Therapeutics
APVO
$1.43M
| – | – |
0
| – | – |
2016 Q3
4 quarters
|
|
1553
DELISTED
T2 Biosystems, Inc
TTOO
| $59K | ﹤0.01% |
+3
| New | +$55.7K |
2017 Q3
0 quarters
|
|
1554
Harmonic Inc
HLIT
$1.12B
| $54K | ﹤0.01% |
+17,800
| New | +$66.1K |
2017 Q3
0 quarters
|
|
1555
Acacia Research
ACTG
$406M
| $53K | ﹤0.01% |
11,646
-2,254
| -16% | -$8.43K |
2016 Q4
3 quarters
|
|
1556
CareDx
CDNA
$4.19B
| $53K | ﹤0.01% |
+14,350
| New | +$30.1K |
2017 Q3
0 quarters
|
|
|
ENT
1557
DELISTED
Global Eagle Entertainment Inc.
ENT
| $52K | ﹤0.01% |
+609
| New | +$47.7K |
2017 Q3
0 quarters
|
|
1558
Vivani Medical
VANI
$76.8M
| $50K | ﹤0.01% |
+1,742
| New | +$48.7K |
2017 Q3
0 quarters
|
|
1559
DELISTED
Asensus Surgical, Inc.
ASXC
| $50K | ﹤0.01% |
2,674
-1,548
| -37% | -$18K |
2017 Q2
1 quarter
|
|
|
CEMP
1560
DELISTED
Cempra, Inc.
CEMP
| $50K | ﹤0.01% |
+15,407
| New | +$54.4K |
2017 Q3
0 quarters
|
|
1561
Altimmune
ALT
$323M
| $49K | ﹤0.01% |
+710
| New | +$52.9K |
2017 Q3
0 quarters
|
|
|
BBG
1562
DELISTED
Bill Barrett Corp
BBG
| $48K | ﹤0.01% |
11,183
-179,321
| -94% | -$595K |
2015 Q3
8 quarters
|
|
1563
FuelCell Energy
FCEL
$832M
| $47K | ﹤0.01% |
74
-78
| -51% | -$42.1K |
2017 Q2
1 quarter
|
|
|
TLRA
1564
DELISTED
Telaria, Inc.
TLRA
| $47K | ﹤0.01% |
+10,800
| New | +$31.5K |
2017 Q3
0 quarters
|
|
|
ELGX
1565
DELISTED
Endologix Inc
ELGX
| $47K | ﹤0.01% |
+1,063
| New | +$48.4K |
2017 Q3
0 quarters
|
|
1566
Information Services Group
III
$295M
| $46K | ﹤0.01% |
+11,326
| New | +$43.6K |
2017 Q3
0 quarters
|
|
1567
Microbot Medical
MBOT
$69.9M
| $46K | ﹤0.01% |
+2,593
| New | +$45.7K |
2017 Q3
0 quarters
|
|
1568
DELISTED
Mr. Cooper
COOP
| $45K | ﹤0.01% |
3,952
-1,031
| -21% | -$14.5K |
2016 Q4
3 quarters
|
|
|
NIHD
1569
DELISTED
NII Holdings, Inc. Common Stock
NIHD
| $44K | ﹤0.01% |
95,080
+54,646
| +135% | +$32.2K |
2017 Q2
1 quarter
|
|
1570
DELISTED
Seadrill Limited Common Stock
SDRL
| $40K | ﹤0.01% |
427
-2,240
| -84% | -$195K |
2016 Q4
3 quarters
|
|
1571
MannKind Corp
MNKD
$1.33B
| $39K | ﹤0.01% |
17,857
-51,817
| -74% | -$81.3K |
2016 Q4
3 quarters
|
|
|
IMBI
1572
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
| $39K | ﹤0.01% |
3,790
+680
| +22% | +$6.98K |
2016 Q4
3 quarters
|
|
|
ATHX
1573
DELISTED
Athersys, Inc. Common Stock
ATHX
| $36K | ﹤0.01% |
+703
| New | +$31.7K |
2017 Q3
0 quarters
|
|
1574
Rigel Pharmaceuticals
RIGL
$868M
| $33K | ﹤0.01% |
+1,294
| New | +$31.5K |
2017 Q3
0 quarters
|
|
1575
Vaalco Energy
EGY
$586M
| $32K | ﹤0.01% |
+38,800
| New | +$31.4K |
2017 Q3
0 quarters
|
|
Similar funds
Squarepoint's Q3 2017 Portfolio in Review
As of Q3 2017, Squarepoint held 2,083 positions worth $5.2B, up 2.3% from $5.08B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint's Q3 2017 filing shows 588 new, 511 increased, 480 reduced and 501 closed positions. Its largest new stake was iShares MSCI Japan ETF: 1,203,234 shares worth $67M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $274M.
By sector, the portfolio is most concentrated in Miscellaneous at 14% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
- Squarepoint's largest Q3 2017 buy was iShares MSCI Japan ETF: 1,203,234 shares worth $67M.
- Squarepoint added most to Invesco QQQ Trust in Q3 2017, an estimated $65.8M increase.
- Squarepoint's biggest Q3 2017 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $274M.
- Squarepoint fully exited iShares MSCI Taiwan ETF in Q3 2017, selling an estimated $93.6M.
- Squarepoint's ten largest holdings make up 11% of its $5.2B portfolio in Q3 2017.
- Squarepoint opened 588 new positions and closed 501 in Q3 2017.
- Squarepoint's portfolio value rose 2.3% quarter-over-quarter to $5.2B.
Based on Squarepoint's 13F filing for Q3 2017, filed 14 Nov 2017.